A 30-Day Brain Reset Reversed Aging Markers in Mice
Key Takeaways
-
In mice, Menin levels declined with age in specific neurons within the hypothalamus, a brain region that helps coordinate metabolism, temperature, sleep, appetite, and hormone signals.
-
Reducing Menin activity caused a cluster of aging-related changes in mice, including more inflammation, weaker cognition, thinner skin, lower bone mass, and modestly shorter lifespan.
-
Increasing Menin in older mice improved several of those measures after 30 days, including learning, memory, balance, skin thickness, and bone mass.
-
D-serine—a signaling amino acid—improved learning and memory in older mice but did not reproduce the broader physical changes linked with Menin restoration.
-
Neither Menin-targeting treatment nor D-serine supplementation is established as safe or effective for healthy aging in people.
A Control Center for Aging?
The hypothalamus is a small brain region with outsize influence over the body’s daily rhythms and metabolic signals. Researchers have increasingly wondered whether age-related changes in this control center could ripple outward, affecting tissues far beyond the brain.
In the original mouse experiments, loss of Menin in a select group of hypothalamic neurons was enough to produce multiple aging-like changes. Restoring Menin in older mice appeared to reverse some of them, suggesting the protein may be one part of a larger brain-to-body signaling network.
The D-Serine Finding
The researchers found that declining Menin was accompanied by lower D-serine, a molecule involved in communication between nerve cells. Giving older mice D-serine in their drinking water for three weeks improved performance on learning and memory tasks.
But it is important not to turn that result into a supplement recommendation. The D-serine intervention did not restore bone or skin measures, and later work suggests its effects can vary substantially with biological context. High-dose use has also raised kidney-safety concerns in animal research.
A Larger Research Direction
The Menin paper itself was published in 2023, while the current coverage places it within a growing body of mouse research on how brain circuits, metabolism, inflammation, and aging may influence one another.
That is the real significance: not evidence of a ready-made anti-aging treatment, but an expanding hypothesis that aging may be shaped partly by signals originating in the brain. Testing that idea safely in people remains a major scientific challenge.
References:
- Haijiao Zhao, Meimei Liao, Ran Huo, Ting He, Hongni Tian, Zeqi Li, Chen Chen, Ziqing Yu, Juan Chai, Xiaocui Song, Ruichao Shao, Shuhua Ying, Wen Gao, Ling Liu, Di Sang, Qi Li, Haohong Li, Fengchao Wang, Dapeng Ju, Eric Erquan Zhang. Restoring circadian rhythms in the hypothalamic paraventricular nucleus reverses aging biomarkers and extends lifespan in male mice. Cell, 2026; 189 (7): 2007 DOI: 10.1016/j.cell.2026.01.016
- Kentaro Mori, Shin-ichiro Imai. Muscle-derived Mimecan regulates hypothalamus-brown adipose tissue communication and promotes health and lifespan in mice. Cell Metabolism, 2026; 38 (7): 1425 DOI: 10.1016/j.cmet.2026.04.003
- Lige Leng, Ziqi Yuan, Xiao Su, Zhenlei Chen, Shangchen Yang, Meiqin Chen, Kai Zhuang, Hui Lin, Hao Sun, Huifang Li, Maoqiang Xue, Jun Xu, Jingqi Yan, Zhenyi Chen, Tifei Yuan, Jie Zhang. Hypothalamic Menin regulates systemic aging and cognitive decline. PLOS Biology, 2023; 21 (3): e3002033 DOI: 10.1371/journal.pbio.3002033